文献速递脑血管病

基于孟德尔随机化在百万退伍军人计划和英国生物银行中鉴定卒中进展相关蛋白

Protein Identification for Stroke Progression via Mendelian Randomization in Million Veteran Program and UK Biobank.
PubMed 文献 · Stroke · 2024-07-22

研究在百万退伍军人计划和英国生物银行中对首发卒中后主要不良心血管事件(MACE,51 929例/39 980对照)和动脉缺血性卒中(AIS,45 120例/46 789对照)进行全基因组关联研究,并用孟德尔随机化分析1463种血浆蛋白对后续MACE的影响,发现CCL27和TNFRSF14两个蛋白与后续MACE相关,提示炎症是首发AIS后MACE的 contributing factor。

要点

  • rs76472767(RNF220附近)与后续AIS相关,OR 0.75(95%CI 0.64-0.85),P=3.69×10⁻⁸。
  • rs13294166(LINC01492附近)与后续MACE相关,OR 1.52(95%CI 1.37-1.67),P=3.77×10⁻⁸。
  • CCL27对后续MACE效应OR 0.77(95%CI 0.66-0.88),TNFRSF14效应OR 1.42(95%CI 1.24-1.60)。

核心结论

  • 两个对首发卒中影响很小的蛋白似乎影响首发AIS后的后续MACE,提示炎症是首发AIS后MACE的 contributing factor,并凸显潜在新靶点。

研究设计与样本

  • 在百万退伍军人计划和英国生物银行中对首发卒中后的MACE(51 929例/39 980对照)和AIS(45 120例/46 789对照)进行全基因组关联研究,并用蛋白数量性状位点对1463种血浆蛋白丰度进行孟德尔随机化分析。

主要发现

  • rs76472767(RNF220附近)与后续AIS显著相关,OR 0.75(95%CI 0.64-0.85),P=3.69×10⁻⁸。
  • rs13294166(LINC01492附近)与后续MACE显著相关,OR 1.52(95%CI 1.37-1.67),P=3.77×10⁻⁸。
  • 孟德尔随机化识别出2个对卒中后后续MACE有影响的蛋白:CCL27效应OR 0.77(95%CI 0.66-0.88),校正P=0.05;TNFRSF14效应OR 1.42(95%CI 1.24-1.60),校正P=0.006。
  • 这两个蛋白与新发AIS无关,并被认为在炎症中发挥作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individuals who have experienced a stroke, or transient ischemic attack, face a heightened risk of future cardiovascular events. Identification of genetic and molecular risk factors for subsequent cardiovascular outcomes may identify effective therapeutic targets to improve prognosis after an incident stroke. METHODS: We performed genome-wide association studies for subsequent major adverse cardiovascular events (MACE; ncases=51 929; ncontrols=39 980) and subsequent arterial ischemic stroke (AIS; ncases=45 120; ncontrols=46 789) after the first incident stroke within the Million Veteran Program and UK Biobank. We then used genetic variants associated with proteins (protein quantitative trait loci) to determine the effect of 1463 plasma protein abundances on subsequent MACE using Mendelian randomization. RESULTS: Two variants were significantly associated with subsequent cardiovascular events: rs76472767 near gene RNF220 (odds ratio, 0.75 [95% CI, 0.64-0.85]; P=3.69×10-8) with subsequent AIS and rs13294166 near gene LINC01492 (odds ratio, 1.52 [95% CI, 1.37-1.67]; P=3.77×10-8) with subsequent MACE. Using Mendelian randomization, we identified 2 proteins with an effect on subsequent MACE after a stroke: CCL27 ([C-C motif chemokine 27], effect odds ratio, 0.77 [95% CI, 0.66-0.88]; adjusted P=0.05) and TNFRSF14 ([tumor necrosis factor receptor superfamily member 14], effect odds ratio, 1.42 [95% CI, 1.24-1.60]; adjusted P=0.006). These proteins are not associated with incident AIS and are implicated to have a role in inflammation. CONCLUSIONS: We found evidence that 2 proteins with little effect on incident stroke appear to influence subsequent MACE after incident AIS. These associations suggest that inflammation is a contributing factor to subsequent MACE outcomes after incident AIS and highlights potential novel targets.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Elmore AR, Adhikari N, Hartley AE, et al. Protein Identification for Stroke Progression via Mendelian Randomization in Million Veteran Program and UK Biobank. Stroke. 2024. PMID: 39038097. doi:10.1161/STROKEAHA.124.047103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。